AzTrials
AzTrials

Research institution

Amsterdam UMC, location VUmc Clinical Trials

Studies where Amsterdam UMC, location VUmc is the lead sponsor: what is enrolling now, by phase, condition and country.

305 registered studies

In numbers

Open to volunteers
61
Active
70
With results posted
4
All registered
305

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 61

Completed, with results posted

All 4
  • Diabetes Mellitus, Diabetic Kidney Disease

    DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study

    • Completed
    • Age: 35 to 80 years
    • Phase 4
    • Results posted

    SGLT2 inhibitors such as ertugliflozin improve blood pressure and kidney outcomes in people living with diabetes through incompletely understood mechanisms, however, not all patients treated with SGLT2 inhibition have improved…

    Conditions
    Diabetes Mellitus, Diabetic Kidney Disease, Hypertension
    Trial name
    DESIGN (NCT05727579)
    Testing
    Salt-Diet and/or Ertugliflozin, Ertugliflozin 15 mg
    Where
    Netherlands
    Volunteers
    41 people
    Sponsor
    Amsterdam UMC, location VUmc
    Can I take part? DESIGN
  • Parkinson Disease, Impaired Cognition

    Cognitive Training in Parkinson Study

    • Completed
    • Age: All ages
    • Lifestyle or therapy programme
    • Results posted

    This study evaluates the efficacy of an eight-week online cognitive training program on objective and subjective cognitive functions in Parkinson's disease.

    Conditions
    Parkinson Disease, Impaired Cognition, Alteration in Cognition
    Trial name
    cogtips (NCT02920632)
    Testing
    Online cognitive training 1, Online cognitive training 2
    Where
    Netherlands
    Volunteers
    167 people, healthy volunteers welcome
    Sponsor
    Amsterdam UMC, location VUmc
    Can I take part? cogtips
  • RheumatoId Arthritis

    The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study

    • Completed
    • Age: 65 years and older
    • Phase 4
    • Results posted

    Comparing the cost-effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis: The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (GLORIA)

    Trial name
    Gloria (NCT02585258)
    Testing
    Prednisolone
    Where
    28 sites in Germany, Hungary and 5 more
    Volunteers
    451 people
    Sponsor
    Amsterdam UMC, location VUmc
    Can I take part? Gloria
  • Diabetes Mellitus, Type 2, Hypercholesterolemia

    Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)

    • Completed
    • Age: 18 to 75 years
    • Phase 4
    • Results posted

    Objective: To investigate the effect of 5 weeks dapagliflozin 10 mg once daily treatment on glucose and lipid fluxes in patients with type 2 diabetes. Study design: Single center single arm (mechanistic) intervention trial.

    Trial name
    DICE (NCT03074630)
    Testing
    Dapagliflozin, Rosuvastatin
    Where
    Netherlands
    Volunteers
    12 people
    Sponsor
    Amsterdam UMC, location VUmc
    Can I take part? DICE

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in